The chief executive of the drugmaker Novo Nordisk, Lars Fruergaard Jørgensen, is scheduled to face tough questions Tuesday on Capitol Hill about the high costs of the company’s widely popular weight-loss drugs.

Jørgensen will appear before the Senate Committee on Health, Education, Labor and Pensions during a livestreamed hearing Tuesday starting at 10 a.m. ET.

The head of the committee, Sen. Bernie Sanders, I-Vt., has been vocal about his frustrations over how much Novo Nordisk charges Americans for both Ozempic (used to treat type 2 diabetes) and Wegovy (approved for weight loss).

In general, we pay by far the highest prices in the world for prescription drugs. Same exact medicine sold in Canada, Europe is a fraction of what it is in the United States,” Sanders said in an interview Monday. “The result of that is that hundreds of thousands of people in this country who desperately need this product will not be able to afford it.”

  • @[email protected]
    link
    fedilink
    English
    79 hours ago

    if you’re exploring these avenues simply to lose weight you’re lazy

    Fuck off. I guarantee you that every single person considering medication to control weight has tried exercise and diet.

    • @Bassman27
      link
      English
      -88 hours ago

      You sound like a fat guy lmao

    • @snekerpimp
      link
      English
      -18 hours ago

      Bull shit, I know people that are not clinically obese fighting with their insurers to get this covered. If you think the main purchaser is someone who needs it, I wish I was as naïve as you.